The global pernicious anemia diagnosis and treatment market is anticipated to grow at a considerable CAGR of 7.1% during the forecast period (2021-2027). However, the COVID-19 had sidelined the diagnosis and treatment of other major as well as minor diseases. Pernicious anemia is one of them which are caused by the deficiency of vitamin B12. Diabetic elders are most likely to have this disease, however, youngsters are also found to have this disease. The main cause of this disease is the disability of the body to sustain essential nutrients and their removal through urine. Lots of scientific research had also published that deficiency of vitamin B12 is also responsible for the increasing fatality rate in some parts of the globe. If COVID-19 patients if have given a surplus nutritional supplement of vitamin B12 then chances of complexity get highly reduced in that case as now lots of COVID-19 patients are now losing their life due to their self-defense system, ‘antibodies’.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/pernicious-anemia-diagnosis-and-treatment-market
The deficiency of vitamin B12 disturbs the immune system of our body due to which our antibodies start killing healthy cells of our stomach. In a very critical case, the infected portion of the stomach may need to be removed. This disease is named pernicious as it was earlier known to be a life-threatening disease, however, with the advancement of medical science this disease can now be treated with injections or even oral supplements of vitamin B12. According to the Journal of Blood Medicine, pernicious anemia is a rare condition with only 0.1% of prevalence in the general population and 1.9% in the elder people above 60 years. However, 50% of the reported anemia cases are of pernicious anemia type.
A Full Report of Global Pernicious Anemia Diagnosis and Treatment Market is Available at: https://www.omrglobal.com/industry-reports/pernicious-anemia-diagnosis-and-treatment-market
The pharmaceutical companies involved in the diagnosis and treatment of pernicious anemia are not very active or having less attention towards this disease due to them that there are very limited treatments available for this disease. However, it is expected that due to the impact of this disease in COVID-19 complications will pull the attention of market players and governments towards this disease, and soon this market will start growing with supportive initiatives, investments, and awareness.
Global Pernicious Anemia Diagnosis and Treatment Market Report Segment
By Diagnosis
- Complete Blood Count Test
- Vitamin B-12 Deficiency Test
- Biopsy
- Intrinsic Factor Deficiency Test
By Treatment
- Vitamin B-12 Injections
- Vitamin B-12 Pills
- Other
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
